Optomed Oyj (HEL:OPTOMED)
Finland
· Delayed Price · Currency is EUR 4.090
-0.010 (-0.24%)
May 14, 2025, 12:57 PM EET
Optomed Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 15.73 | 15.04 | 15.1 | 14.66 | 14.85 | 13.01 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0.16 | Upgrade
|
| Revenue | 15.73 | 15.04 | 15.1 | 14.66 | 14.85 | 13.17 | Upgrade
|
| Revenue Growth (YoY) | 5.25% | -0.40% | 3.00% | -1.28% | 12.77% | -13.54% | Upgrade
|
| Cost of Revenue | 5.59 | 5.37 | 4.86 | 5.45 | 5.1 | 4.21 | Upgrade
|
| Gross Profit | 10.15 | 9.67 | 10.24 | 9.21 | 9.75 | 8.96 | Upgrade
|
| Selling, General & Admin | 9.89 | 9.64 | 9.33 | 9.61 | 9.38 | 7.74 | Upgrade
|
| Other Operating Expenses | 3.8 | 3.49 | 2.69 | 2.39 | 2.91 | 1.95 | Upgrade
|
| Operating Expenses | 16.06 | 15.43 | 14.2 | 14.11 | 14.5 | 11.7 | Upgrade
|
| Operating Income | -5.92 | -5.77 | -3.95 | -4.9 | -4.75 | -2.75 | Upgrade
|
| Interest Expense | -0.37 | -0.16 | -0.2 | -0.12 | -0.1 | -0.17 | Upgrade
|
| Interest & Investment Income | 0.04 | 0.18 | 0.02 | 0 | 0.02 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.5 | 0.5 | -0.31 | -0.2 | 0.47 | -0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | -0.08 | -0.05 | -0.15 | 0.07 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | -5.83 | -5.33 | -4.5 | -5.35 | -4.29 | -3.09 | Upgrade
|
| Asset Writedown | -0.19 | -0.19 | -0.02 | -1.04 | -0.57 | -0.16 | Upgrade
|
| Other Unusual Items | - | - | - | 0.84 | 0.54 | - | Upgrade
|
| Pretax Income | -6.02 | -5.52 | -4.52 | -5.55 | -4.33 | -3.25 | Upgrade
|
| Income Tax Expense | -0.08 | -0.07 | -0.08 | -0.08 | -0.08 | -0.07 | Upgrade
|
| Earnings From Continuing Operations | - | -5.45 | -4.44 | -5.47 | -4.25 | -3.18 | Upgrade
|
| Net Income to Company | - | -5.45 | -4.44 | -5.47 | -4.25 | -3.18 | Upgrade
|
| Net Income | -5.94 | -5.45 | -4.44 | -5.47 | -4.25 | -3.18 | Upgrade
|
| Net Income to Common | -5.94 | -5.45 | -4.44 | -5.47 | -4.25 | -3.18 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 19 | 17 | 15 | 13 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 17 | 15 | 13 | 13 | Upgrade
|
| Shares Change (YoY) | 11.78% | 11.78% | 14.11% | 8.92% | 1.35% | 48.43% | Upgrade
|
| EPS (Basic) | -0.31 | -0.29 | -0.27 | -0.37 | -0.32 | -0.24 | Upgrade
|
| EPS (Diluted) | -0.31 | -0.29 | -0.27 | -0.37 | -0.32 | -0.24 | Upgrade
|
| Free Cash Flow | -1.25 | -1.87 | -0.83 | -3.15 | -3.4 | -3.07 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.10 | -0.05 | -0.21 | -0.25 | -0.23 | Upgrade
|
| Gross Margin | 64.48% | 64.27% | 67.83% | 62.83% | 65.64% | 68.01% | Upgrade
|
| Operating Margin | -37.61% | -38.34% | -26.18% | -33.41% | -31.97% | -20.85% | Upgrade
|
| Profit Margin | -37.76% | -36.24% | -29.41% | -37.33% | -28.61% | -24.13% | Upgrade
|
| Free Cash Flow Margin | -7.93% | -12.44% | -5.48% | -21.49% | -22.91% | -23.31% | Upgrade
|
| EBITDA | -5.19 | -5.1 | -3.28 | -4.12 | -3.99 | -1.98 | Upgrade
|
| EBITDA Margin | -32.95% | -33.88% | -21.69% | -28.10% | -26.87% | -15.04% | Upgrade
|
| D&A For EBITDA | 0.73 | 0.67 | 0.68 | 0.78 | 0.76 | 0.77 | Upgrade
|
| EBIT | -5.92 | -5.77 | -3.95 | -4.9 | -4.75 | -2.75 | Upgrade
|
| EBIT Margin | -37.61% | -38.34% | -26.18% | -33.41% | -31.97% | -20.85% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.